Weill Cornell Medicine researchers have discovered a mechanism that ovarian tumors use to cripple immune cells and impede their attack - blocking the ...
The istaroxime patent is entitled, “ISTAROXIME-CONTAINING INTRAVENOUS FORMULATION FOR THE TREATMENT OF PRE-CARDIOGEN1C SHOCK AND CARDIOGENIC SHOCK”, is No. PCT/US2023/018998 and was assigned ...
Sung-Min Hwang, a postdoctoral associate in Dr. Cubillos-Ruiz's lab who led the new study. Dr. Hwang discovered that in patient-derived tumor specimens and mouse models of ovarian cancer, FABP5 ...